Shiga toxin-associated hemolytic uremic syndrome: A narrative review

A Joseph, A Cointe, P Mariani Kurkdjian, C Rafat… - Toxins, 2020 - mdpi.com
The severity of human infection by one of the many Shiga toxin-producing Escherichia coli
(STEC) is determined by a number of factors: the bacterial genome, the capacity of human …

[PDF][PDF] Emerging foodborne pathogens: Escherichia coli O157: H7 as a model of entry of a new pathogen into the food supply of the developed world

GL Armstrong, J Hollingsworth, JG Morris Jr - 1996 - Citeseer
In 1982, an investigation by the Centers for Disease Control and Prevention (CDC) of two
outbreaks of severe bloody diarrhea, associated with the same fastfood restaurant chain, led …

[HTML][HTML] Epidemiology of Escherichia coli O157: H7 outbreaks, united states, 1982–2002

JM Rangel, PH Sparling, C Crowe… - Emerging infectious …, 2005 - ncbi.nlm.nih.gov
Escherichia coli O157: H7 causes 73,000 illnesses in the United States annually. We
reviewed E. coli O157 outbreaks reported to Centers for Disease Control and Prevention …

Escherichia coli O157:H7 and the Hemolytic–Uremic Syndrome

TG Boyce, DL Swerdlow, PM Griffin - New England Journal of …, 1995 - Mass Medical Soc
In the decade since its initial description in the Journal, 1 Escherichia coli O157: H7 has
emerged as a major cause of both sporadic cases and outbreaks of diarrhea in North …

Clinical features of anti-factor H autoantibody–associated hemolytic uremic syndrome

MA Dragon-Durey, SK Sethi, A Bagga… - Journal of the …, 2010 - journals.lww.com
Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy
that associates, in 70% of cases, with genetic or acquired disorders leading to dysregulation …

Hemolytic Uremic Syndrome and Death in Persons with Escherichia coli O157:H7 Infection, Foodborne Diseases Active Surveillance Network Sites, 2000–2006

LH Gould, L Demma, TF Jones, S Hurd… - Clinical Infectious …, 2009 - academic.oup.com
Background. Hemolytic uremic syndrome (HUS) is a life-threatening illness usually caused
by infection with Shiga toxin-producing Escherichia coli O157 (STEC O157). We evaluated …

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome …

JT Kielstein, G Beutel, S Fleig, J Steinhoff… - Nephrology Dialysis …, 2012 - academic.oup.com
Background May 22nd marks the beginning of a Shiga-toxin-producing Escherichia coli
(STEC) O104: H4 outbreak in Northern Germany. By its end on 27 July, it had claimed 53 …

Long-term outcomes of Shiga toxin hemolytic uremic syndrome

JM Spinale, RL Ruebner, L Copelovitch, BS Kaplan - Pediatric nephrology, 2013 - Springer
Shiga toxin-producing Escherichia coli (STEC) hemolytic uremic syndrome (HUS) is an
important cause of acute kidney injury (AKI). The outcomes of STEC HUS have improved …

The United States national prospective hemolytic uremic syndrome study: microbiologic, serologic, clinical, and epidemiologic findings

N Banatvala, PM Griffin, KD Greene… - The Journal of …, 2001 - academic.oup.com
The frequency of Shiga toxin–producing Escherichia coli (STEC) serotypes associated with
postdiarrheal hemolytic uremic syndrome (HUS) cases among children and adults in the …

Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157: H7 enteritis: a meta-analysis

N Safdar, A Said, RE Gangnon, DG Maki - Jama, 2002 - jamanetwork.com
ContextThe use of antibiotics for treatment of Escherichia coli O157: H7 infection has
become controversial since a recent small study found that it may increase the risk of …